Moreover, STAT3 has been implicated in mediating β-cell epithelial–mesenchymal transition in the context of chronic pancreatitis-related diabetes, where its activation promotes β-cell dedifferentiation and loss, further contributing to diabetes progression (43). Here, STAT3 is linked to diabetes mellitus.